Molecular Reclassification to Find Clinically Useful Biomarkers for Systemic Autoimmune Diseases

Principal Investigators:

• PIERLUIGI MERONI

Financing institution:

EUROPEAN COMMISSION

Type:

JTI_IMI - Joint Technology Iniziative_Innovative Medicines Initiative (IMI)

Project leader:

UCB Pharma SA (IRIS)

Year:

2014

Duration:

60

Status:

Closed